Shopping News / Articles
Bitget
bitget. com > amp > news > detail > 12560605357523

GSK Claims Top Trading Spot With $260 Million Turnover as Autism Drug Withdrawal Shocks Market

4+ hour, 48+ min ago  (540+ words) Bitget GSK Claims Top Trading Spot With $260 Million Turnover as Autism Drug Withdrawal Shocks Market The primary catalyst for the heightened trading activity and the subsequent slight price adjustment was the confirmation that GSK withdrew its application for the drug…...

Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > jetstream-venture-fund-secures-positions-120000775. html

Jetstream Venture Fund Secures Positions in Surf Therapeutics and Hill Research, Bolstering Health Tech and AI Portfolios

11+ hour, 22+ min ago  (179+ words) SCOTTSDALE, Ariz. , April 10, 2026 /PRNewswire/ -- Jetstream Venture Fund (Jetstream), an innovative interval fund designed to expand access to venture-style investing for a wider mainstream audience, today announced the closing of two strategic startup investments: Surf Therapeutics and Hill Research. Led by…...

Investing. com UK
uk. investing. com > news > company-news > fda-clears-mesoblast-dmd-trial-for-ryoncil-in-children-93 CH-4603111

FDA clears Mesoblast DMD trial for Ryoncil in children By Investing. com

7+ hour, 4+ min ago  (250+ words) European defense stocks tumble, construction gains on Ukraine peace deal talk FTSE 100 today: Stocks flat as ceasefire hopes offset Middle East tensions What 2022 got right: Three lessons for the latest energy shock Sterling today: Pound steadies near weekly high as…...

Trading View
tradingview. com > symbols > NASDAQ-ABVX > options-chain

ABVX Options Chain " NASDAQ: ABVX " Trading View

2+ hour, 49+ min ago  (73+ words) Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development…...

News-Medical
news-medical. net-medical. net

Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar

19+ min ago  (190+ words) More specifically, the upcoming event will highlight new capabilities across the Pharma. AI ecosystem, including the MMAI Gym for Science, updates to core modules such as Panda Omics, Generative Biologics, and Chemistry42. Alex Aliper, Ph D, President, Insilico Medicine During the…...

Whalesbook
whalesbook. com > news > English > healthcarebiotech > Indias-Biopharma-SHAKTI-Syngene-Biocon-Divis-Take-Different-Routes > 69d9b1f3e0ea10058dbaedda

India's Biopharma SHAKTI: Syngene, Biocon, Divi's Take Different Routes

53+ min ago  (296+ words) Whalesbook India's Biopharma Push India's Biopharma SHAKTI initiative injects Rs 10, 000 crore to boost biologics and biosimilars, aiming to transform the nation into a global biomanufacturing hub This government program marks a strategic shift for India, moving beyond generic drugs to…...

open PR. com
openpr. com > news > 4464727 > leading-companies-enhancing-their-presence-in-the-cell

Leading Companies Enhancing Their Presence in the Cell Processing Technologies Market

14+ hour, 38+ min ago  (51+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....

Proactiveinvestors UK
proactiveinvestors. co. uk > companies > news > 1090382 > biovie-ceo-explains-bezisterim-parkinson-s-trial-results-icymi-1090382. html

Bio Vie CEO explains Bezisterim Parkinson's trial results - ICYMI

1+ hour, 11+ min ago  (312+ words) Bio Vie Inc (NASDAQ: BIVI, NASDAQ: BIVIW) earlier this week outlined its evolving approach to Parkinson's disease, with CEO Cuong Do highlighting the company's focus on neuroinflammation and insulin resistance as key drivers of the condition. Speaking to Proactive, Do…...

@gurufocus
gurufocus. com > news > 8786827 > gsk-withdraws-approval-for-wellcovorin-drug-amid-market-changes

GSK Withdraws Approval for Wellcovorin Drug Amid Market Changes

16+ hour, 23+ min ago  (171+ words) The GF Score" ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score" values have been found to generate higher long-term returns (backtested 2006-2021). There has been no insider buying…...

Nasdaq Company News
view. news. eu. nasdaq. com > view

Expre S2ion Strengthens Glyco-Engineering Platform with Publication of Patent Application

20+ hour, 37+ min ago  (170+ words) view. news. eu. nasdaq. com H'rsholm, Denmark, 10 April 2026 " Expre S2ion Biotech Holding AB's affiliate Expre S2ion Biotechnologies Ap S (Expre S2ion"), a clinical-stage biotechnology company with a pipeline of novel immunotherapies targeting oncology and infectious diseases, today announces the publication of its patent…...

Shopping

Please enter a search for detailed shopping results.